Bandara, N., Stott Reynolds, T. J., Schehr, R., Bandari, R. P., Diebolder, P. J., Krieger, S., . . . Smith, C. J. (2018). Matched-pair, (86)Y/(90)Y-labeled, Bivalent RGD/Bombesin Antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a Potential Theranostic Agent for Prostate Cancer. Nucl Med Biol.
Citação norma ChicagoBandara, Nilantha, et al. "Matched-pair, (86)Y/(90)Y-labeled, Bivalent RGD/Bombesin Antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], As a Potential Theranostic Agent for Prostate Cancer." Nucl Med Biol 2018.
Citação norma MLABandara, Nilantha, et al. "Matched-pair, (86)Y/(90)Y-labeled, Bivalent RGD/Bombesin Antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], As a Potential Theranostic Agent for Prostate Cancer." Nucl Med Biol 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.